Showing results (51-60 of 19,455) with videos related to

Sort By:
Pageof 1,946
Lancet (London, England)|December 15, 2022
9 months of delamanid, linezolid, levofloxacin, and pyrazinamide versus conventional therapy for treatment of fluoroquinolone-sensitive multidrug-resistant tuberculosis (MDR-END): a multicentre, randomised, open-label phase 2/3 non-inferiority trial in South KoreaJeongha Mok, Myungsun Lee, Deog Kyeom Kim, et al.
Lancet (London, England)|December 15, 2022
Challenges and opportunities for educating health professionals after the COVID-19 pandemicJulio Frenk, Lincoln C Chen, Latha Chandran, et al.
Lancet (London, England)|June 12, 2022
ThalassaemiaAntonis Kattamis, Janet L Kwiatkowski, Yesim Aydinok
Lancet (London, England)|June 12, 2022
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trialGrace Li, Federica Cappuccini, Natalie G Marchevsky, et al.
Lancet (London, England)|November 27, 2022
The evolving landscape of pulmonary arterial hypertension clinical trialsJason Weatherald, Athénaïs Boucly, Anthony Peters, et al.
Lancet (London, England)|June 19, 2022
Once daily oral relugolix combination therapy versus placebo in patients with endometriosis-associated pain: two replicate phase 3, randomised, double-blind, studies (SPIRIT 1 and 2)Linda C Giudice, Sawsan As-Sanie, Juan C Arjona Ferreira, et al.
Lancet (London, England)|June 19, 2022
Opioid versus opioid-free analgesia after surgical discharge: a systematic review and meta-analysis of randomised trialsJulio F Fiore, Charbel El-Kefraoui, Marc-Aurele Chay, et al.
Lancet (London, England)|June 19, 2022
Life expectancy by county, race, and ethnicity in the USA, 2000-19: a systematic analysis of health disparities
Lancet (London, England)|July 22, 2023
SyphilisRosanna W Peeling, David Mabey, Xiang-Sheng Chen, et al.
Lancet (London, England)|June 9, 2024
Burr-hole drainage with or without irrigation for chronic subdural haematoma (FINISH): a Finnish, nationwide, parallel-group, multicentre, randomised, controlled, non-inferiority trialRahul Raj, Pihla Tommiska, Timo Koivisto, et al.
Pageof 1,946